Mona Mashayekhi
Assistant Professor of Medicine · Vanderbilt University Medical Center
Credentials: · · · · ·
History
- 2005–2009
Research
Type I interferon is selectively required by dendritic cells for immune rejection of tumors
The Journal of Experimental Medicine · 2011 · 924 citations
Immunity · 2011 · First of 11 authors · 345 citations
Compensatory dendritic cell development mediated by BATF-IRF interactions
Nature · 2012 · 343 citations
28 papers
24 papers · 1 as a fellow
- SB
23 papers · 8 as a fellow
- CG
22 papers · 4 as a fellow
14 papers
14 papers
13 papers
13 papers
Grants
- 2023–2028
The Effect of SGLT2 Inhibition on Adipose Tissue Inflammation and Endothelial Function
National Heart, Lung, and Blood Institute · K23
Contact PI · $741.7K · Vanderbilt University Medical Center
Clinical trials
- 2023–2026
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
Principal investigator · Recruiting · Phase 1, Phase 2
Vanderbilt University Medical Center
- 2021–2023
SGLT2 Inhibitor Effects on Inflammation and Heart Disease in Obesity Pilot
Principal investigator · Completed · Phase 1, Phase 2
Vanderbilt University Medical Center